Ablation therapies can be used for the treatment of various diseases across several medical domains such as ophthalmology, cancer, gynecology, and cardiovascular. Being a minimally invasive procedure, it is less painful than conventional surgical operations, leading to shorter recovery time. In addition, it causes very little damage to the surrounding tissues. Even though it lowers the side effects, it has some disadvantages as well. For instance, large and bulky tissues, such as bone and neck nodules, cannot be treated with ablation. Besides, the availability of ablation treatment in remote locations is quite restricted.
Comprehensive competitive analysis and profiles of major market players, such as
The key players profiled in this report include St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Conmed Corporation, Olympus Corporation, Smith & Nephew plc, BTG plc, and Johnson & Johnson. Other players in the ablation devices market include Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra LifeSciences Holdings Corporation, Abbott Laboratories, and Terumo Corporation.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the Ablation Devices Market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers Ablation Devices Market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Ablation Devices Market growth.
Ophthalmology segment would be the most lucrative segment for investment in the ablation devices market for the new as well as existing players. This is because there are numerous players, products, and patents already available in the market for cancer and cardiology ablation devices, making the competitive rivalry intense. However, ophthalmology segment has untapped areas that could provide great opportunities for new entrants as well as existing players.
Presently, North America and Europe have the highest growth potential due to established reimbursement policies, high buying power, rapid adoption of minimal-invasive therapies, rise in the count of aging population, and increasing prevalence of patients with chronic illnesses. However, the market would gain traction in the developing regions of Asia-Pacific and Latin America as well, due to the increase in urbanization & disposable income, large number of undiagnosed patients, and growing awareness about ablation devices.
The key players profiled in this report include Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., St. Jude Medical, Inc., Medtronic plc, Conmed Corporation, Olympus Corporation, Johnson & Johnson, Smith & Nephew plc, and BTG plc.
